- Home
- IMRN vs SCNX Comparison
IMRN vs SCNX Comparison
Compare IMRN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SCNX
- Stock Information
- Founded
- IMRN 1994
- SCNX 2010
- Country
- IMRN Australia
- SCNX United States
- Employees
- IMRN N/A
- SCNX N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- IMRN Health Care
- SCNX Health Care
- Exchange
- IMRN Nasdaq
- SCNX Nasdaq
- Market Cap
- IMRN 15.0M
- SCNX 13.1M
- IPO Year
- IMRN N/A
- SCNX 2020
- Fundamental
- Price
- IMRN $2.74
- SCNX $7.13
- Analyst Decision
- IMRN Strong Buy
- SCNX
- Analyst Count
- IMRN 1
- SCNX 0
- Target Price
- IMRN $5.00
- SCNX N/A
- AVG Volume (30 Days)
- IMRN 6.0K
- SCNX 15.5K
- Earning Date
- IMRN 10-15-2024
- SCNX 11-10-2024
- Dividend Yield
- IMRN N/A
- SCNX N/A
- EPS Growth
- IMRN N/A
- SCNX N/A
- EPS
- IMRN N/A
- SCNX N/A
- Revenue
- IMRN $3,271,194.00
- SCNX N/A
- Revenue This Year
- IMRN N/A
- SCNX N/A
- Revenue Next Year
- IMRN N/A
- SCNX N/A
- P/E Ratio
- IMRN N/A
- SCNX N/A
- Revenue Growth
- IMRN 171.67
- SCNX N/A
- 52 Week Low
- IMRN $1.48
- SCNX $3.69
- 52 Week High
- IMRN $5.96
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- IMRN 55.49
- SCNX N/A
- Support Level
- IMRN $2.66
- SCNX N/A
- Resistance Level
- IMRN $2.87
- SCNX N/A
- Average True Range (ATR)
- IMRN 0.14
- SCNX 0.00
- MACD
- IMRN 0.01
- SCNX 0.00
- Stochastic Oscillator
- IMRN 67.09
- SCNX 0.00
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.